antigenic blocking peptide  (Alomone Labs)

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: Post-embedding immunoEM for NMDA-GluN2B reveals labeling in the postsynaptic density of layer III rhesus macaque dlPFC spines. Electron micrograph depicting a layer III dlPFC spine receiving a synapse (white arrows) from an axonal bouton. Post-embedding immunoEM preparation reveals immunogold particles (black arrowheads) labeling NMDAR-GluN2B in the postsynaptic density. Adapted from .

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Labeling

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: Higher proportion of extrasynaptic GluN2B immunogold particles in layer III SGC spines than dlPFC spines. (A) Electron micrograph depicting spines in SGC layer III. (A1) An SGC spine (sp, pseudocolored yellow) with NMDAR-GluN2B immunogold particles (green arrowheads) in the postsynaptic density of a synapse (black arrows) formed by an axonal bouton (ax, pseudocolored blue). The spine contains a spine apparatus, an extension of the smooth endoplasmic reticulum (SER, pseudocolored pink) in the spine neck. (A2,A3) SGC spines with NMDAR-GluN2B appearing adhered to extrasynaptic membranes (orange arrowheads), near the SER. In A3, the extrasynaptic NMDAR-GluN2B is apposed to a structure consistent with glial morphology (gl, pseudocolored green), and the bouton contains a presynaptic cytoplasmic NMDAR-GluN2B (blue arrowhead) among the vesicles. (B) Electron micrographs depicting spines in dlPFC layer III. (B1,B2) dlPFC spines containing synaptic NMDAR-GluN2B (green arrowheads), and cytosolic NMDAR-GluN2B (gray arrowheads), which are likely being trafficked. (B3) A dlPFC spine with an extrasynaptic NMDAR-GluN2B in the spine neck, apposed to a structure consistent with glial morphology, and near a spine apparatus. (C) Nested pie charts depicting the location of NMDAR-GluN2B immunogold particles in spines of SGC (left), and dlPFC (right) in Monkey 1 (M1, inside) and Monkey 2 (M2, outside). Percent of NMDAR-GluN2B immunogold particles found in the cytoplasm (gray), post-synaptic density (green), perisynaptic membrane (yellow-green), and extrasynaptic membrane (orange) of NMDAR-GluN2B+ spines. (D) Plot depicting the location of membrane-bound NMDAR-GluN2B immunogold particles, in relation to the synapse, averaged across M1 and M2. Error bars depict standard deviation. One-way ANOVA, F (5,6 = 67.71, p < 0.001, with post-hoc Tukey’s test). * p < 0.05; ** p < 0.01, *** p < 0.001; **** p < 0.0001; scale bars, 200 nm. ax, axon; gl, glial process; mit, mitochondria; mvb, multivesicular body; SER, smooth endoplasmic reticulum spine apparatus; sp, spine.

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Membrane, Standard Deviation

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: Higher extrasynaptic expression in dendrites of putative excitatory neurons of SGC than dlPFC. (A) Electron micrographs from layer III SGC. (A1) A putative excitatory dendrite, labeled with MAP2+ non-nickel immunoperoxidase diaminobenzidine (smudge-like precipitate, double-headed arrows), expressing an extrasynaptic NMDAR-GluN2B (orange arrowhead); (A2,A3) NMDAR-GluN2B at extrasynaptic (orange arrowheads), cytoplasmic (gray arrowheads), or near-synaptic locations (gray-white striped arrowhead) in putative excitatory dendrites. (B) Electron micrographs from layer III dlPFC. (B1) A putative excitatory dendrite, with a spine in plane, expressing cytoplasmic and extrasynaptic NMDAR-GluN2B. (B2) A putative excitatory dendrite, labeled with MAP2, expressing extrasynaptic and cytoplasmic NMDAR-GluN2B. (C) Nested pie charts depicting the percent of NMDAR-GluN2B immunogold particles found at cytoplasmic, extrasynaptic, perisynaptic, and synaptic locations in MAP2+ dendritic shafts in SGC (left) and dlPFC (right) of Monkey 1 (inside) and Monkey 2 (outside). Synapses on the shaft of MAP2+ dendrites were rare, and synaptic NMDAR-GluN2B on MAP2+ shaft synapses was extremely rare (<0.2% of all immunogold particles in all areas analyzed). (D) Mean percent of extrasynaptic NMDAR-GluN2B immunogold particles across all MAP2+ dendrites in SGC and dlPFC. One-way ANOVA with post-hoc Tukey’s test, F (3,4) = 1,691, p < 0.0001. * p < 0.05; pink pseudocolor, SER spine apparatus; black arrows, synapse; scale bars, 200 nm; ax, axon; dend, dendrite; MAP2, microtubule-associated protein-2; mit, mitochondria; sp, spine.

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Expressing, Labeling

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: Extrasynaptic NMDAR-GluN2B expressed at a pyramidal-like soma in layer III SGC. (A) A panorama of stitched electron micrographs depicting a pyramidal-like soma and dendrites (pseudocolored yellow), including the nucleus (pseudocolored plum) and its axon initial segment (pseudocolored blue). NMDAR-GluN2B is prevalently expressed in extrasynaptic membranes (orange arrowheads) at the soma and proximal processes. Black boxes depict inset locations for subsequent panels. (B–G) Insets from (A) depicting extrasynaptic NMDAR-GluN2B at higher magnification. (H) Inset from (A) selected to emphasize the antibody labeling specificity of the labeled neuron compared to the surrounding neuropil as well as to emphasize nuclear labeling. Few NMDAR-GluN2B immunoparticles are evident in the surrounding neuropil, while the pyramidal-like soma densely expresses cytosolic NMDAR-GluN2B immunoparticles (gray arrowheads). NMDAR-GluN2B immunoparticles are also present in the nucleus (pseudocolored plum, white arrowhead). (I) Inset from (A) depicting several more extrasynaptic NMDAR-GluN2B on a basal dendrite as well as a symmetric synapse (double arrowheads) formed on the soma (axon pseudocolored red). Scale bars in (B–I) , 200 nm.

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Antibody Labeling, Labeling

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: NMDAR-GluN2B is expressed in inhibitory dendrites in layer III SGC and dlPFC. Electron micrographs depicting high-likelihood inhibitory dendrites in SGC (A) and dlPFC (B) . Dendrites were deemed high-likelihood inhibitory dendrites by the lack of spines in the plane and the presence of two or more asymmetric synapses formed on the dendritic shaft as inhibitory dendrites in the cortex are sparsely spiny or aspiny . (A1–A3) Examples of NMDAR-GluN2B immunogold labeling in high-likelihood inhibitory dendrites found in layer III SGC. (B1,B2) Examples of NMDAR-GluN2B immunogold labeling in high-likelihood inhibitory dendrites found in layer III dlPFC. (C) Nested pie charts depicting the location of NMDAR-GluN2B immunogold particles in high-likelihood dendrites of SGC (left) and dlPFC (right) for Monkey 1 (inside) and Monkey 2 (outside). No statistically significant differences were detected between dlPFC and SGC. Scale bars, 200 nm. ax, axon; dend, dendrite; gl, glial process; mit, mitochondria.

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Labeling

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: NMDAR-GluN2B are expressed at equivalent levels across CBP+ inhibitory neurons in layer III SGC and dlPFC. (A,B) Maximum projection images from confocal z-stacks obtained in layer III SGC (A) and dlPFC (B) depicting multiple immunofluorescence labeling for PV (red), CB (yellow), CR (magenta), and NMDAR-GluN2B (cyan). Color-coded arrows depict inhibitory neurons, and double-headed arrows indicate CB+ pyramidal neurons, which are faintly labeled and pyramidal in shape. (C,D) We sampled imaging fields in layer III of both SGC and the dlPFC for quantification of NMDAR-GluN2B expression across neurons labeled for the CBPs. Stacked bar charts depicting the mean proportion of PV (red), CB (yellow), and CR (magenta) that fell into negative, weak, moderate, or strong NMDAR-GluN2B expression bins as determined by the mean intensity (MI) in the NMDAR-GluN2B channel. “GluN2B-negative” is defined by an MI at or below the average amount in immunonegative sampled “background” neuropil regions. “GluN2B-strong” is defined by MI at or above the average found in nearby morphologically identified pyramidal-like neurons expressing NMDAR-GluN2B. See for more detailed information about the inhibitory neuron analysis that produced these plots. CB, calbindin; CR, calretinin; PV, parvalbumin.

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Immunofluorescence, Labeling, Imaging, Expressing, Produced

Journal: Frontiers in Neuroanatomy

Article Title: Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices

doi: 10.3389/fnana.2025.1553056

Figure Lengend Snippet: Schematic illustrating how extrasynaptic NMDAR-GluN2B may contribute to SGC hyperactivity and/or calcium-mediated neurodegeneration-related events. (A) Schematic depicting a spine (yellow), receiving a synapse from a glutamatergic bouton (blue), with an astrocytic leaflet (green) near the synapse. A synaptic NMDAR-GluN2B is present in the synapse (green), and an extrasynaptic NMDAR-GluN2B (orange) is present near the astrocytic process. (B) A magnified view showing that the bouton releases glutamate (gray circles) toward the postsynaptic density (thick black band), where the green synaptic NMDAR-GluN2B is engaged and calcium ions (pink), as well as sodium (Na+) ions, flow into the spine. AMPA receptors in the post-synaptic density also allow an influx of sodium ions (Na+), although these are emphasized less as they are not the focus of the present study. Incoming calcium ions can trigger feedforward calcium release ( ; ), via (1) direct calcium-mediated calcium release from the smooth endoplasmic reticulum (SER) by activation of primarily Ryanodine receptors (RyR), and (2) by cAMP magnification of calcium release, whereby calcium activates AC to produce cAMP, which activates PKA signaling. PKA, in turn, phosphorylates the SER calcium channels RyR and IP3R to further increase calcium release. Glutamate escaping out of the synaptic cleft is sequestered into the astrocyte via the EAAT, where it can be converted to glutamine. In the dlPFC, calcium influx can also lead to a reduction in delay-related firing via SK3 channels (not shown). (C) If the EAATs are perturbed or downregulated, then glutamate can more readily engage extrasynaptic NMDA-GluN2B. Evidence suggests that there may be glial pathology in the SGC during states of depression [ reviewed in , , , and ]. Given the prevalence of extrasynaptic NMDA-GluN2B, we have found in the present study, we hypothesize that these may contribute to SGC hyperactivity observed in depression, perhaps by engaging feedforward calcium mechanisms and increasing depolarization (yellow arrow). (D) Rapid-acting antidepressants that antagonize NMDA receptors may work in part by blocking extrasynaptic NMDAR-GluN2B in the SGC . (E) Calcium is normally tightly regulated by cytosolic buffering mechanisms (e.g., calbindin and mitochondria) and by phosphodiesterases (which catabolize cAMP). Loss of this regulation with aging and/or inflammation ( ; ; ) can dysregulate feedforward calcium signaling. Very high levels of cytosolic calcium can activate calpain-2, which cleaves and disinhibits GSK3β and cdk5, kinases that hyperphosphorylate tau, producing toxic species like pT217Tau . Further post-translational modifications lead to tau fibrillation and the formation of neurofibrillary tangles. AC, adenylyl cyclase; cAMP, cyclic adenosine monophosphate; cdk5, cyclin-dependent kinase 5; EAAT, excitatory amino acid transporter; GSK3β, glycogen synthase kinase 3 beta; IP3R, inositol triphosphate receptor; PKA, protein kinase A; SER, smooth endoplasmic reticulum spine apparatus; RyR, ryanodine receptor.

Article Snippet: One section was run in tandem with the above, but incubated in antibody dilution buffer containing the Alomone NMDAR-GluN2B primary antibody, but with the addition of the blocking peptide for the NMDAR-GluN2B antigen (Alomone, cat# BLP-GC003), at 10x the concentration of the primary antibody ( ).

Techniques: Activation Assay, Blocking Assay

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: Hemoglobin scavenger receptor CD163 is associated with hepatobiliary injury in sickle cell disease (SCD). A : representative images of immunofluorescence (IF) analysis of SCD patient biopsied liver samples show abundant CD163-positive cells. B , left : representative IF images (merged and single channels) of colocalization assay show higher percentage of CD163 colocalized with positive F4/80 staining of Kupffer cells in SCD mouse liver. Right : bar graph depicts the Pearson’s coefficient of colocalization in control (CON) and SCD mouse liver. C , left : representative IF images (merged and single channels) of colocalization assay show higher percentage of CD163 colocalized with positive CD11b staining of monocytes in SCD mouse liver. Right : bar graph depicts the Pearson’s coefficient of colocalization in control and SCD mouse liver. The error bars represent SD. Arrowheads indicate liver sinusoidal endothelial cells. * P < 0.05, ** P < 0.01. Scale bars, 50 µm.

Article Snippet: For competitive binding assay, the mice were injected with Antigenic Blocking Peptide CD163 N-epitope (FabGennix) via tail vein (iv) with three different doses of the blocker: 0.1 mg/kg, 1 mg/kg, and 3 mg/kg.

Techniques: Immunofluorescence, Staining, Control

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: CD163 blocker competes with hemoglobin (Hb) for binding. A : schematic showing the experimental plan to analyze the effect of CD163 blocker in sickle cell disease (SCD) mouse liver. B : bar graph depicting the results of heme ELISA assay post administration of CD163 blocker in the plasma of SCD mice. C : schematic showing the experimental plan to examine the mode of action of the CD163 blocker used in blocking CD163-Hb binding. HO-1, heme oxygenase-1. D : bar graphs depicting the results of heme ELISA assay post CD163 blocker administration in the plasma of SCD mice. oxHb, oxyhemoglobin; Veh, vehicle. The error bars represent SD. * P < 0.05. Figure created with BioRender.com.

Article Snippet: For competitive binding assay, the mice were injected with Antigenic Blocking Peptide CD163 N-epitope (FabGennix) via tail vein (iv) with three different doses of the blocker: 0.1 mg/kg, 1 mg/kg, and 3 mg/kg.

Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Clinical Proteomics, Blocking Assay

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: Heme oxygenase-1 (HO-1) positively regulates CD163 level in sickle cell disease (SCD) mouse liver. A and B : representative immunohistochemistry image ( A ) and colocalization analysis ( B ) show increased colocalization of CD163 and HO-1 in hepatic Kupffer cells of SCD mouse liver. CON, control. C : qRT-PCR analysis of hepatocytes and nonhepatocytes isolated from control mouse liver exhibits increased expression of both CD163 and HO-1 in the nonhepatocyte cell population. D : the representative images acquired during proximity ligation assay (PLA) show increased interactions between CD163 and HO-1 in SCD mice compared to littermate control mice. Scale bars, 50 µm. E : fluorescence intensity quantification of PLA demonstrating significantly higher intensity in the SCD group compared to control mice. FOV, field of view. F and G : series of Western blot micrographs (for the treatment pattern see ) showing the levels of HO-1 in liver lysates of control mice, untreated SCD mice, and SCD mice after treatment with iron dextran ( F ) and treatments with clodronate and hemoglobin as well as undergoing hypoxic conditions ( G ). H , left : representative Western blot micrographs showing decreased levels of CD163 protein expression after HO-1 knockdown in Hep3B human hepatoma cell line compared with untreated cells. Right : densitometric analysis of micrographs shows significantly reduced levels of CD163 protein expression after HO-1 knockdown and confirms the efficiency of performed knockdown in control and SCD mouse liver tissue. * P < 0.05; # P < 0.06–0.08.

Article Snippet: For competitive binding assay, the mice were injected with Antigenic Blocking Peptide CD163 N-epitope (FabGennix) via tail vein (iv) with three different doses of the blocker: 0.1 mg/kg, 1 mg/kg, and 3 mg/kg.

Techniques: Immunohistochemistry, Control, Quantitative RT-PCR, Isolation, Expressing, Proximity Ligation Assay, Fluorescence, Western Blot, Knockdown

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: The CD163 and heme oxygenase-1 (HO-1) signaling pathway in sickle cell disease (SCD)-related liver complications. Schematic diagram depicting the HO-1-CD163 interaction in SCD mouse liver. Cell-free hemoglobin (Hb) released after intravascular hemolysis is scavenged by plasma haptoglobin (HP), which chaperones it to the liver for hemoglobin scavenger receptor CD163-dependent clearance by macrophages. Cell-free Hb on its own can also bind to CD163, albeit less efficiently. In both cases, it leads to endocytosis and degradation of Hb and the release of heme. HO-1 metabolizes heme to produce carbon monoxide, iron, and biliverdin. Along with its role in heme degradation, HO-1 also regulates CD163 expression in the hepatic Kupffer cells. Loss of HO-1 in the liver reduces CD163 expression, which can further impact the Hb-heme metabolism in SCD liver. RBC, red blood cell. Figure created with BioRender.com.

Article Snippet: For competitive binding assay, the mice were injected with Antigenic Blocking Peptide CD163 N-epitope (FabGennix) via tail vein (iv) with three different doses of the blocker: 0.1 mg/kg, 1 mg/kg, and 3 mg/kg.

Techniques: Clinical Proteomics, Expressing

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: Hemoglobin scavenger receptor CD163 is associated with hepatobiliary injury in sickle cell disease (SCD). A : representative images of immunofluorescence (IF) analysis of SCD patient biopsied liver samples show abundant CD163-positive cells. B , left : representative IF images (merged and single channels) of colocalization assay show higher percentage of CD163 colocalized with positive F4/80 staining of Kupffer cells in SCD mouse liver. Right : bar graph depicts the Pearson’s coefficient of colocalization in control (CON) and SCD mouse liver. C , left : representative IF images (merged and single channels) of colocalization assay show higher percentage of CD163 colocalized with positive CD11b staining of monocytes in SCD mouse liver. Right : bar graph depicts the Pearson’s coefficient of colocalization in control and SCD mouse liver. The error bars represent SD. Arrowheads indicate liver sinusoidal endothelial cells. * P < 0.05, ** P < 0.01. Scale bars, 50 µm.

Article Snippet: CD163 activity was blocked with Antigenic Blocking Peptide CD163 N-epitope (FabGennix), which was administered subcutaneously at the dose of 1 mg/kg mouse body weight or as mentioned in the text.

Techniques: Immunofluorescence, Staining, Control

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: CD163 blocker competes with hemoglobin (Hb) for binding. A : schematic showing the experimental plan to analyze the effect of CD163 blocker in sickle cell disease (SCD) mouse liver. B : bar graph depicting the results of heme ELISA assay post administration of CD163 blocker in the plasma of SCD mice. C : schematic showing the experimental plan to examine the mode of action of the CD163 blocker used in blocking CD163-Hb binding. HO-1, heme oxygenase-1. D : bar graphs depicting the results of heme ELISA assay post CD163 blocker administration in the plasma of SCD mice. oxHb, oxyhemoglobin; Veh, vehicle. The error bars represent SD. * P < 0.05. Figure created with BioRender.com.

Article Snippet: CD163 activity was blocked with Antigenic Blocking Peptide CD163 N-epitope (FabGennix), which was administered subcutaneously at the dose of 1 mg/kg mouse body weight or as mentioned in the text.

Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Clinical Proteomics, Blocking Assay

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: Heme oxygenase-1 (HO-1) positively regulates CD163 level in sickle cell disease (SCD) mouse liver. A and B : representative immunohistochemistry image ( A ) and colocalization analysis ( B ) show increased colocalization of CD163 and HO-1 in hepatic Kupffer cells of SCD mouse liver. CON, control. C : qRT-PCR analysis of hepatocytes and nonhepatocytes isolated from control mouse liver exhibits increased expression of both CD163 and HO-1 in the nonhepatocyte cell population. D : the representative images acquired during proximity ligation assay (PLA) show increased interactions between CD163 and HO-1 in SCD mice compared to littermate control mice. Scale bars, 50 µm. E : fluorescence intensity quantification of PLA demonstrating significantly higher intensity in the SCD group compared to control mice. FOV, field of view. F and G : series of Western blot micrographs (for the treatment pattern see ) showing the levels of HO-1 in liver lysates of control mice, untreated SCD mice, and SCD mice after treatment with iron dextran ( F ) and treatments with clodronate and hemoglobin as well as undergoing hypoxic conditions ( G ). H , left : representative Western blot micrographs showing decreased levels of CD163 protein expression after HO-1 knockdown in Hep3B human hepatoma cell line compared with untreated cells. Right : densitometric analysis of micrographs shows significantly reduced levels of CD163 protein expression after HO-1 knockdown and confirms the efficiency of performed knockdown in control and SCD mouse liver tissue. * P < 0.05; # P < 0.06–0.08.

Article Snippet: CD163 activity was blocked with Antigenic Blocking Peptide CD163 N-epitope (FabGennix), which was administered subcutaneously at the dose of 1 mg/kg mouse body weight or as mentioned in the text.

Techniques: Immunohistochemistry, Control, Quantitative RT-PCR, Isolation, Expressing, Proximity Ligation Assay, Fluorescence, Western Blot, Knockdown

Journal: American Journal of Physiology - Cell Physiology

Article Title: Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease

doi: 10.1152/ajpcell.00386.2023

Figure Lengend Snippet: The CD163 and heme oxygenase-1 (HO-1) signaling pathway in sickle cell disease (SCD)-related liver complications. Schematic diagram depicting the HO-1-CD163 interaction in SCD mouse liver. Cell-free hemoglobin (Hb) released after intravascular hemolysis is scavenged by plasma haptoglobin (HP), which chaperones it to the liver for hemoglobin scavenger receptor CD163-dependent clearance by macrophages. Cell-free Hb on its own can also bind to CD163, albeit less efficiently. In both cases, it leads to endocytosis and degradation of Hb and the release of heme. HO-1 metabolizes heme to produce carbon monoxide, iron, and biliverdin. Along with its role in heme degradation, HO-1 also regulates CD163 expression in the hepatic Kupffer cells. Loss of HO-1 in the liver reduces CD163 expression, which can further impact the Hb-heme metabolism in SCD liver. RBC, red blood cell. Figure created with BioRender.com.

Article Snippet: CD163 activity was blocked with Antigenic Blocking Peptide CD163 N-epitope (FabGennix), which was administered subcutaneously at the dose of 1 mg/kg mouse body weight or as mentioned in the text.

Techniques: Clinical Proteomics, Expressing